Come up with a name for your new list and we'll add to it:
Cyrano Therapeutics raised a round of funding on October 31, 2017. Investors include
New Summit BioPharma.
Cyrano Therapeutics has developed a proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. The Cyrano product repurposes an approved molecule for this n…